HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

OPEN ACCESS ARTICLE

This Article Free via Open Access: OA OA Full Text Full Text (PDF) OA All Versions of this Article: 2007-1104v1 26/8/2173    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosová, I. Articles by Nolta, J. A. Search for Related Content PubMed PubMed Citation Articles by Rosová, I. Articles by Nolta, J. A.

TRANSLATIONAL AND CLINICAL RESEARCH

Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells

^aDivision of Oncology, Hematopoietic Development and Malignancy Program, Washington University School of Medicine, St. Louis, Missouri, USA;
^bDepartment of Internal Medicine, Stem Cell Program, University of California, Davis, Sacramento, California, USA

Key Words. Immune-deficient mice • Human stem cells • Mesenchymal stem cells • Hypoxia • Transplantation • Tissue repair

Correspondence: Correspondence: Jan A. Nolta, Ph.D., Stem Cell Program, University of California at Davis, Room 653, 2425 Stockton Boulevard, Sacramento, California 95817, USA. Telephone: 916-453-2335; Fax: 916-453-2173; e-mail: Jan.nolta{at}ucdmc.ucdavis.edu

Received on January 4, 2008; accepted for publication on May 14, 2008.

First published online in STEM CELLS EXPRESS  May 29, 2008.

Mesenchymal stem cells (MSC) are adult multipotent cells found in bone marrow, adipose tissue, and other adult tissues. MSC have been shown to improve regeneration of injured tissues in vivo, but the mechanisms remain unclear. Typically, MSC are cultured under ambient, or normoxic, conditions (21% oxygen). However, the physiological niches for MSC in the bone marrow and other sites have much lower oxygen tension. When used as a therapeutic tool to repair tissue injuries, MSC cultured in standard conditions must adapt from 21% oxygen in culture to less than 1% oxygen in the ischemic tissue. We therefore examined the effects of preculturing human bone marrow-derived MSC in hypoxic conditions (1%–3% oxygen) to elucidate the best conditions that enhance their tissue regenerative potential. We demonstrated that MSC cultured in hypoxia activate the Akt signaling pathway while maintaining their viability and cell cycle rates. We also showed that MSC cultured in hypoxia induced expression of cMet, the major receptor for hepatocyte growth factor (HGF), and enhanced cMet signaling. MSC cultured in hypoxic conditions increased their migration rates. Since migration and HGF responsiveness are thought to be key mediators of MSC recruitment and/or activation in vivo, we next examined the tissue regenerative potential of MSC cultured under hypoxic conditions, using a murine hind limb ischemia model. We showed that local expression of HGF is increased in ischemic muscle in this model. Intra-arterial injection of MSC cultured in either normoxic or hypoxic conditions 24 hours after surgical induction of hind limb ischemia enhanced revascularization compared with saline controls. However, restoration of blood flow was observed significantly earlier in mice that had been injected with hypoxic preconditioned MSC. Collectively, these data suggest that preculturing MSC under hypoxic conditions prior to transplantation improves their tissue regenerative potential.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				A. Carriere, T. G. Ebrahimian, S. Dehez, N. Auge, C. Joffre, M. Andre, S. Arnal, M. Duriez, C. Barreau, E. Arnaud, et al. Preconditioning by Mitochondrial Reactive Oxygen Species Improves the Proangiogenic Potential of Adipose-Derived Cells-Based Therapy Arterioscler. Thromb. Vasc. Biol., July 1, 2009; 29(7): 1093 - 1099. [Abstract] [Full Text] [PDF]

				S. Wisel, M. Khan, M. L. Kuppusamy, I. K. Mohan, S. M. Chacko, B. K. Rivera, B. C. Sun, K. Hideg, and P. Kuppusamy Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 543 - 550. [Abstract] [Full Text] [PDF]

				C.-C. Wang, C.-H. Chen, S.-M. Hwang, W.-W. Lin, C.-H. Huang, W.-Y. Lee, Y. Chang, and H.-W. Sung Spherically Symmetric Mesenchymal Stromal Cell Bodies Inherent with Endogenous Extracellular Matrices for Cellular Cardiomyoplasty Stem Cells, March 1, 2009; 27(3): 724 - 732. [Abstract] [Full Text] [PDF]

				W. Li and R. L. Silverstein Biological Surgery: Synergetic Angiogenic Therapy Using Coadministration of Two Progenitor Cell Populations Circ. Res., September 26, 2008; 103(7): 684 - 686. [Full Text] [PDF]